Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Listen to this summary
The authors aimed to evaluate the efficacy of inhaled treprostinil in slowing lung function decline and improving clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF) by analyzing combined results from the TETON-1 and TETON-2 trials. The study found that treprostinil significantly reduced the rate of decline in forced vital capacity and delayed clinical worsening compared to placebo, with additional benefits observed in quality of life and other secondary endpoints. These findings support the use of inhaled treprostinil as a treatment option for IPF patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from American journal of respiratory and critical care medicine
View all →Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 22, 2026 · American journal of respiratory and critical care medicine
Metered-Dose Liquid Nitrogen Cryospray for Chronic Bronchitis: Results From the Prospective, Sham-Controlled Trial (SPRAY-CB)
Sep 21, 2026 · American journal of respiratory and critical care medicine
Alveolar Ventilation Efficiency Assessed via Capnography is Associated with Improved Outcomes in Pediatric Cardiac Arrest
Jun 12, 2026 · American journal of respiratory and critical care medicine
Defining disease stability in COPD: Evidence from Phase 3 clinical trials
Jun 11, 2026 · American journal of respiratory and critical care medicine
Association of White Blood Cell Count with Treatment Response to Cefepime vs Piperacillin-Tazobactam
Jun 11, 2026 · American journal of respiratory and critical care medicine
Identification of Pulmonary Arterial Hypertension Patients with Venous or Capillary Involvement
More in Internal Medicine
View all →Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
